Clinical trial
Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian…
NCT00132626 · Institute for Neurodegenerative Disorders, Other · Completed
Key facts
| NCT number | NCT00132626 |
|---|---|
| Title | Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome |
| Official title | Dynamic SPECT Imaging With [123I]ß-CIT in Patients With Parkinsonism |
| Lead sponsor | Institute for Neurodegenerative Disorders, Other |
| Collaborators | Molecular NeuroImaging National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease, Parkinsonian Syndrome |
| Intervention type | Drug |
| Interventions | [123I]ß-CIT and SPECT imaging |
| Enrollment | 500 |
| Start date | Sep 1, 1992 |
| Completion | Aug 1, 2005 |
| First posted | Aug 22, 2005 |
| Last update posted | Apr 3, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: